Hints and tips:
...I remember flicking through the playbill and seeing the posters for the season’s upcoming shows, and wondering if I would somehow be able to swing a trip to Manhattan and catch Sarah Jessica Parker and Matthew...
...lina.saigol@ft.com...
...Additional reporting by George Parker...
...Sir Malcolm Rifkind, the former Conservative foreign secretary who chairs parliament’s Intelligence and Security Committee, said he had been fully briefed on the attack by Andrew Parker, the new director-general...
...Additional reporting by George Parker, Patrick Jenkins and Brooke Masters...
...Additional reporting by Sylvia Pfeifer, Lina Saigol, David Oakley and Mark Wembridge...
...“The big change has been in the $1bn to $5bn range, where deal count and deal volumes have risen sharply,” said Paul Parker, head of global M&A at Barclays Capital....
...Paul Parker, the head of global M&A at Barclays Capital, said that US companies were very active in looking at emerging market opportunities....
...“M&A has really returned,” said Paul Parker, global head of M&A for Barclays Capital....
...Additional reporting by George Parker and Kate Burgess in London...
...Sir John Parker, Anglo American chairman, said the rejection followed consultation with investors: “We have made our position on Xstrata’s proposal very clear and we welcome the Panel’s decision today.”...
...“The broader market is still susceptible to negative news,” said Mr Parker....
...The turning point for Xstrata came in July when Anglo appointed Sir John Parker as chairman....
...Paul Parker, head of global M&A at Barclays Capital, said last year’s broken deals would lead boards to be more cautious: “As a board member, I’d want to be paying attention to certainty of value and particularly...
...John Parker, chairman of National Grid; Paolo Scaroni, chief executive of Eni; and Jeroen van der Veer, the outgoing head of Royal Dutch Shell, are all thought to be on the short-list....
...History is on the side of the companies that buy at the bottom,” Mr Parker says....
...Parker Hannifin, the US group which owns a life sciences unit, and Millipore, the multinational bioscience company that provides technologies and services for the discovery, development and production of...
International Edition